Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Oral retinoid for severe psoriasis; strict pregnancy-prevention rules. | The most powerful acne treatment — with strict safety rules. |
| Body system | Skin & Hair | Skin & Hair |
| Drug class | Retinoids | Retinoids |
| Supply | Prescription only | Prescription only |
| Main uses | Severe psoriasis, Severe ichthyosis and other keratinisation disorders | Severe nodular or scarring acne, Acne that hasn't responded to antibiotics |
| How it works | Slows skin cell growth and scaling. | Shrinks oil glands and stops pores clogging. |
| Starts working | 2–3 months | — |
| Half-life | About 2 days (etretinate formation with alcohol: up to 120 days) | 10–20 hours |
| Typical adult dose | 25–30 mg once a day with food. | 0.5–1 mg/kg a day with fatty food, usually for 16–24 weeks. |
| Forms | Capsule | Capsule |
| Common side effects | Dry lips and skin, Hair thinning, Peeling hands and feet, Dry eyes, Raised lipids | Very dry lips and skin, Nosebleeds, Dry eyes, Muscle aches, Sun sensitivity |
| Serious side effects | Birth defects, Liver injury, Pancreatitis, Raised pressure inside the skull | Severe birth defects, Depression and suicidal thoughts, Raised skull pressure, Liver and lipid changes, Sexual dysfunction |
| Don't take if | Pregnancy and planned pregnancy within 3 years; Severe liver or kidney impairment; Alcohol in women of childbearing potential; High blood lipids | — |
| Alcohol | Best avoided. Alcohol converts acitretin to etretinate, which stays in the body for years. | — |
| Pregnancy | Usually avoidedCauses severe birth defects. Avoid pregnancy during and for at least 3 years after treatment. | Usually avoidedAbsolutely contraindicated. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | — | 1982 |
| Brand names | United States: SoriataneUnited Kingdom: NeotigasonIndia: Neotigason, Acitretin (generic), Soriatane | United States: Absorica, Claravis, AmnesteemUnited Kingdom: Roaccutane, ReticutanIndia: Isotroin, Sotret, Tretiva |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | D05BB02 | D10BA01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker